235 related articles for article (PubMed ID: 30296012)
1. USP14 as a novel prognostic marker promotes cisplatin resistance via Akt/ERK signaling pathways in gastric cancer.
Fu Y; Ma G; Liu G; Li B; Li H; Hao X; Liu L
Cancer Med; 2018 Nov; 7(11):5577-5588. PubMed ID: 30296012
[TBL] [Abstract][Full Text] [Related]
2. Flotillin-1 promotes progression and dampens chemosensitivity to cisplatin in gastric cancer via ERK and AKT signaling pathways.
Wei J; Wang R; Lu Y; He S; Ding Y
Eur J Pharmacol; 2022 Feb; 916():174631. PubMed ID: 34774850
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
4. SDC2 Stabilization by USP14 Promotes Gastric Cancer Progression through Co-option of PDK1.
You L; Dou Y; Zhang Y; Xiao H; Lv H; Wei GH; Xu D
Int J Biol Sci; 2023; 19(11):3483-3498. PubMed ID: 37496999
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ubiquitin‑specific protease 14 promotes connexin 32 internalization and counteracts cisplatin cytotoxicity in human ovarian cancer cells.
Luo H; Wang X; Ge H; Zheng N; Peng F; Fu Y; Tao L; Wang Q
Oncol Rep; 2019 Sep; 42(3):1237-1247. PubMed ID: 31322234
[TBL] [Abstract][Full Text] [Related]
6. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
Zheng H; Wang JJ; Yang XR; Yu YL
World J Gastroenterol; 2020 Feb; 26(5):499-513. PubMed ID: 32089626
[TBL] [Abstract][Full Text] [Related]
8. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways.
Fu X; Feng J; Zeng D; Ding Y; Yu C; Yang B
Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919028
[TBL] [Abstract][Full Text] [Related]
9. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-specific protease 14 regulates ovarian cancer cisplatin-resistance by stabilizing BCL6 oncoprotein.
Shen J; Hong L; Chen L
Biochem Biophys Res Commun; 2020 Apr; 524(3):683-688. PubMed ID: 32033748
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
Yan R; Li K; Yuan DW; Wang HN; Zhang Y; Dang CX; Zhu K
Int J Oncol; 2018 Dec; 53(6):2566-2578. PubMed ID: 30320337
[TBL] [Abstract][Full Text] [Related]
12. Apoptin-derived peptide reverses cisplatin resistance in gastric cancer through the PI3K-AKT signaling pathway.
Zhou D; Liu W; Liang S; Sun B; Liu A; Cui Z; Han X; Yuan L
Cancer Med; 2018 Apr; 7(4):1369-1383. PubMed ID: 29522284
[TBL] [Abstract][Full Text] [Related]
13. ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance.
Lin L; Li X; Pan C; Lin W; Shao R; Liu Y; Zhang J; Luo Y; Qian K; Shi M; Bin J; Liao Y; Liao W
Cell Death Dis; 2019 Feb; 10(3):173. PubMed ID: 30787271
[TBL] [Abstract][Full Text] [Related]
14. The Zuo Jin Wan Formula increases chemosensitivity of human primary gastric cancer cells by AKT mediated mitochondrial translocation of cofilin-1.
Sun MY; Wang DD; Sun J; Zhao XH; Cai S; Wu QX; Jie T; Ni ZH; Sun JY; Tang QF
Chin J Nat Med; 2019 Mar; 17(3):198-208. PubMed ID: 30910056
[TBL] [Abstract][Full Text] [Related]
15. USP14 de-ubiquitinates vimentin and miR-320a modulates USP14 and vimentin to contribute to malignancy in gastric cancer cells.
Zhu Y; Zhang Y; Sui Z; Zhang Y; Liu M; Tang H
Oncotarget; 2017 Jul; 8(30):48725-48736. PubMed ID: 27448976
[TBL] [Abstract][Full Text] [Related]
16. USP32 promotes tumorigenesis and chemoresistance in gastric carcinoma via upregulation of SMAD2.
Dou N; Hu Q; Li L; Wu Q; Li Y; Gao Y
Int J Biol Sci; 2020; 16(9):1648-1657. PubMed ID: 32226309
[TBL] [Abstract][Full Text] [Related]
17. The long noncoding RNA CRAL reverses cisplatin resistance via the miR-505/CYLD/AKT axis in human gastric cancer cells.
Wang Z; Wang Q; Xu G; Meng N; Huang X; Jiang Z; Chen C; Zhang Y; Chen J; Li A; Li N; Zou X; Zhou J; Ding Q; Wang S
RNA Biol; 2020 Nov; 17(11):1576-1589. PubMed ID: 31885317
[TBL] [Abstract][Full Text] [Related]
18. USP14 inhibition regulates tumorigenesis by inducing apoptosis in gastric cancer.
Lee MY; Kim MJ; Jin JO; Lee PC
BMB Rep; 2023 Aug; 56(8):451-456. PubMed ID: 37401238
[TBL] [Abstract][Full Text] [Related]
19. TCF21 inhibits proliferation and chemoresistance through the AKT pathway in human gastric cancer.
Yang Z; Jiang X; Li D; Dong Q; Zhao H; Jiang X
Gene; 2019 Jan; 682():42-49. PubMed ID: 30296564
[TBL] [Abstract][Full Text] [Related]
20. MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7.
Zhou X; Jin W; Jia H; Yan J; Zhang G
J Exp Clin Cancer Res; 2015 Mar; 34(1):28. PubMed ID: 25888377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
